Skip to main navigation Skip to search Skip to main content

Risk factors for self-harm in people with epilepsy

  • Hayley C. Gorton
  • , Roger T. Webb
  • , W. Owen Pickrell
  • , Matthew J. Carr
  • , Darren M. Ashcroft

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: To estimate the risk of self-harm in people with epilepsy and identify factors which influence this risk. Methods: We identified people with incident epilepsy in the Clinical Practice Research Datalink, linked to hospitalization and mortality data, in England (01/01/1998–03/31/2014). In Phase 1, we estimated risk of self-harm among people with epilepsy, versus those without, in a matched cohort study using a stratified Cox proportional hazards model. In Phase 2, we delineated a nested case–control study from the incident epilepsy cohort. People who had self-harmed (cases) were matched with up to 20 controls. From conditional logistic regression models, we estimated relative risk of self-harm associated with mental and physical illness comorbidity, contact with healthcare services and antiepileptic drug (AED) use. Results: Phase 1 included 11,690 people with epilepsy and 215,569 individuals without. We observed an adjusted hazard ratio of 5.31 (95% CI 4.08–6.89) for self-harm in the first year following epilepsy diagnosis and 3.31 (95% CI 2.85–3.84) in subsequent years. In Phase 2, there were 273 cases and 3790 controls. Elevated self-harm risk was associated with mental illness (OR 4.08, 95% CI 3.06–5.42), multiple general practitioner consultations, treatment with two AEDs versus monotherapy (OR 1.84, 95% CI 1.33–2.55) and AED treatment augmentation (OR 2.12, 95% CI 1.38–3.26). Conclusion: People with epilepsy have elevated self-harm risk, especially in the first year following diagnosis. Clinicians should adequately monitor these individuals and be especially vigilant to self-harm risk in people with epilepsy and comorbid mental illness, frequent healthcare service contact, those taking multiple AEDs and during treatment augmentation.
Original languageEnglish
Pages (from-to)3009-3016
Number of pages8
JournalJournal of Neurology
Volume265
Issue number12
Early online date24 Oct 2018
DOIs
Publication statusPublished - 1 Dec 2018

Data Access Statement

Data from the Clinical Practice Research Datalink (CPRD) were obtained under license from the UK Medicines and Healthcare Products Regulatory. The study was approved by the Independent Scientific Advisory Committee (ISAC) for CPRD research (reference 17_063R). Hayley Gorton has full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. All authors contributed to data analysis.

Funding

This study was funded by the National Institute for Health Research through the Greater Manchester Primary Care Patient Safety Translational Research Centre (NIHR GM PSTRC), Grant no. GMPSTRC-2012-1. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Case–control
  • Cohort
  • Epidemiology
  • Epilepsy
  • Self-harm/self harm

Fingerprint

Dive into the research topics of 'Risk factors for self-harm in people with epilepsy'. Together they form a unique fingerprint.

Cite this